雑誌文献を検索します。書籍を検索する際には「書籍検索」を選択してください。

検索

書誌情報 詳細検索 by 医中誌

Japanese

Concepts and Problems of the Revised Response Criteria in Solid Tumors Kenichi Nakamura 1 , Haruhiko Fukuda 1 1Clinical Trials and Practice Support Division, Center for Cancer Control and Information Services, National Cancer Center, Tokyo Keyword: RECIST , 効果判定規準 , 腫瘍縮小効果 , 第II相試験 pp.1816-1821
Published Date 2009/11/25
DOI https://doi.org/10.11477/mf.1403101795
  • Abstract
  • Look Inside
  • Reference

 The Revised Response Evaluation Criteria in Solid Tumors(RECIST version 1.1)was released in January, 2009. The aim of RECIST is to enhance the comparability of different phase II trials and to prevent ineffective treatment from proceeding to the phase III trial. Therefore, minimizing the variability of the response rate(i.e. precision)in each phase II study is more important in terms of comparability than the closeness to the true value of the response rate(i.e. accuracy). Even when RECIST is inapplicable, additional measures to enhance the comparability such as randomization, masking and independent review are available.


Copyright © 2009, Igaku-Shoin Ltd. All rights reserved.

基本情報

電子版ISSN 1882-1219 印刷版ISSN 0536-2180 医学書院

関連文献

もっと見る

文献を共有